National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving Average – Should You Sell?

Posted by Brian Himes on Jun 10th, 2026

Shares of National Research Corporation (NASDAQ:NRC – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $17.54 and traded as high as $19.90. National Research shares last traded at $19.33, with a volume of 118,652 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

Get Our Latest Research Report on NRC

National Research Price Performance

The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48. The company has a 50 day moving average price of $18.26 and a 200 day moving average price of $17.60. The company has a market capitalization of $484.12 million, a P/E ratio of 54.56 and a beta of 0.37.

National Research (NASDAQ:NRC – Get Free Report) last issued its earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The company had revenue of $34.80 million during the quarter.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 10th. Stockholders of record on Friday, June 26th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.0%. National Research’s dividend payout ratio (DPR) is currently 164.10%.

Institutional Investors Weigh In On National Research

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE lifted its holdings in shares of National Research by 3.0% during the first quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock worth $1,910,000 after buying an additional 3,323 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of National Research during the first quarter worth $226,000. Quantinno Capital Management LP lifted its holdings in shares of National Research by 61.3% during the first quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock worth $1,058,000 after buying an additional 23,682 shares in the last quarter. Heartland Advisors Inc. lifted its holdings in shares of National Research by 374.3% during the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock worth $4,027,000 after buying an additional 187,147 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of National Research by 4.0% during the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock worth $4,257,000 after buying an additional 9,730 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

(Get Free Report)

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.